Quarterly report pursuant to Section 13 or 15(d)

Long-Term Debt and Notes Payable - Narrative (Details)

v3.19.1
Long-Term Debt and Notes Payable - Narrative (Details)
3 Months Ended
Mar. 30, 2019
USD ($)
fiscal_quarter
Amended and Restated Credit Agreement  
Debt Instrument  
Ratio of funded debt to Adjusted EBITDA 3.75
Duration of permitted leverage ratio following acquisition, number of fiscal quarters | fiscal_quarter 4
Amended and Restated Credit Agreement | Maximum  
Debt Instrument  
Ratio of funded debt to Adjusted EBITDA 4.50
Line of Credit | Fourth Amended And Restated Credit Agreement | Revolving Credit Facility  
Debt Instrument  
Maximum borrowing capacity $ 350,000,000
Line of credit facility increase amount $ 150,000,000
Line of Credit | Fourth Amended And Restated Credit Agreement | Revolving Credit Facility | Minimum  
Debt Instrument  
Basis points for commitment fee 0.10%
Line of Credit | Fourth Amended And Restated Credit Agreement | Revolving Credit Facility | Maximum  
Debt Instrument  
Basis points for commitment fee 0.20%
Line of Credit | Fourth Amended And Restated Credit Agreement | Revolving Credit Facility | LIBOR | Minimum  
Debt Instrument  
Basis points for variable interest rate 1.00%
Line of Credit | Fourth Amended And Restated Credit Agreement | Revolving Credit Facility | LIBOR | Maximum  
Debt Instrument  
Basis points for variable interest rate 1.50%
Line of Credit | Fifth Amended and Restated Credit Agreement | Revolving Credit Facility  
Debt Instrument  
Maximum borrowing capacity $ 500,000,000
Line of credit facility increase amount 150,000,000
Credit facility outstanding 115,000,000.0
Revolving line of credit 383,900,000
Line of Credit | Fifth Amended and Restated Credit Agreement | Letter of Credit  
Debt Instrument  
Credit facility allocated (up to) 20,000,000
Outstanding letters of credit $ 1,100,000